Yale Updates on GBM & Meningioma: Are We Seeing Increased Survival Rates With TMZ + RT, Bevacizumab & New Optune Device Treatment? What Are the Meningioma Treatment Modalities?
By
Yale Cancer Center
FEATURING
Nicholas Blondin
February 3, 2021
Login to view comments.
Click here to Login
